DRREDDY Q3 2024-2025 Call Highlights: Record EBITDA, New Launches & Biosimilar Milestones!
● Jan 30, 2025
Dr Reddy’s Laboratories Ltd., an integrated global pharmaceutical company, in its Q3 earnings call discussed a 16% growth in India...
